Monarch Bio Holdings, LLC is a dedicated healthcare holding entity operating three interconnected companies across telehealth, remote patient monitoring, and medical device distribution.
Monarch Bio Holdings, LLC was formed as a dedicated healthcare holding entity — purpose-built to house and scale an integrated remote patient monitoring and clinical services platform. We are not a diversified healthcare conglomerate. We do one thing: build and operate a connected clinical pipeline that moves patients from qualification to monitoring to care efficiently and at scale.
Every company within Monarch Bio plays a defined role. My Virtual Physician provides physician-led qualification and oversight across Primary Care, OBGYN, Endocrinology, and Mental Health. Advanced Wellness Group delivers remote patient monitoring and chronic-care support. VMedical's VMED-S3 is the next-generation monitoring device deploying into the Advanced Wellness channel. Together, they form a connected, closed-loop RPM system.
Monarch Bio Holdings is a subsidiary of Monarch MVP, LLC — a Florida-based private holding company with equity positions across telecommunications, software infrastructure, and healthcare.
Three companies. One seamless pipeline. A patient qualifies once and generates value across every stage of the platform.
Built on real Medicare and Medicare Advantage claim data — not a theoretical workflow. The Monarch Billing Platform is a HIPAA-compliant, cloud-native revenue cycle management system purpose-built for RPM, telehealth, and chronic-care practices. Now available to outside practices.
Explore the Platform →The Monarch Billing Platform was built by Monarch Sol — our in-house technology team — on real Medicare Advantage claim data from our own clinical operations. It handles the billing workflows most RCM vendors don't specialize in: multi-provider RPM, credentialing gaps by MA plan, retro-authorization management, and CPT-level revenue allocation across entities. We are now offering it to qualified medical practices and MSOs.
Each entity within Monarch Bio Holdings plays a distinct and essential role in the clinical pipeline — physician oversight, device distribution, and next-generation monitoring technology.
Monarch Bio Holdings welcomes conversations with healthcare providers, clinical partners, physicians, payers, and device manufacturers who share our focus on building integrated RPM infrastructure across the United States.
Additional company information is available to qualified counterparties on request.
This website is for general informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security. All financial figures are based on verified actuals unless explicitly noted as projected. ¹U.S. RPM market projection per Grand View Research and Precedence Research, 2024.